310 related articles for article (PubMed ID: 7512118)
1. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
Maunders MJ; Petti L; Rowe M
J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
[TBL] [Abstract][Full Text] [Related]
2. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
[TBL] [Abstract][Full Text] [Related]
4. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
Rowe M; Young LS; Cadwallader K; Petti L; Kieff E; Rickinson AB
J Virol; 1989 Mar; 63(3):1031-9. PubMed ID: 2536817
[TBL] [Abstract][Full Text] [Related]
5. The type-specific epitopes of the Epstein-Barr virus nuclear antigen 2 are near the carboxy terminus of the protein.
Rowe DT; Clarke JR
J Gen Virol; 1989 May; 70 ( Pt 5)():1217-29. PubMed ID: 2471806
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
Sample J; Young L; Martin B; Chatman T; Kieff E; Rickinson A; Kieff E
J Virol; 1990 Sep; 64(9):4084-92. PubMed ID: 2166806
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
Sample C; Parker B
Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
[TBL] [Abstract][Full Text] [Related]
8. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection.
Buisson M; Morand P; Genoulaz O; Bourgeat MJ; Micoud M; Seigneurin JM
J Gen Virol; 1994 Feb; 75 ( Pt 2)():431-7. PubMed ID: 8113767
[TBL] [Abstract][Full Text] [Related]
9. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
Chen MR; Tsai CH; Wu FF; Kan SH; Yang CS; Chen JY
J Gen Virol; 1999 Feb; 80 ( Pt 2)():447-455. PubMed ID: 10073707
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody that recognizes Epstein-Barr virus nuclear antigen 2 (EBNA 2) amino acids 1-58 does not react with EBNA 2 in native form, consistent with the self-association of EBNA 2 through the amino-terminus.
Harada S; Obayashi M; Suzuki C; Kitamura R; Eda H; Kikuta H; Satoh H; Sugihara K; Yanagi K
Arch Virol; 2005 May; 150(5):1033-43. PubMed ID: 15662486
[TBL] [Abstract][Full Text] [Related]
11. The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1).
Rumpold H; Rhodes GH; Bloch PL; Carson DA; Vaughan JH
J Immunol; 1987 Jan; 138(2):593-9. PubMed ID: 2432130
[TBL] [Abstract][Full Text] [Related]
12. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
[TBL] [Abstract][Full Text] [Related]
13. Interaction between Epstein-Barr virus-determined nuclear antigen (EBNA) and the viral DNA.
Gergely L; Luka J; Klein G
J Gen Virol; 1984 Nov; 65 ( Pt 11)():2043-8. PubMed ID: 6094716
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.
Falk K; Linde A; Johnson D; Lennette E; Ernberg I; Lundkvist A
J Med Virol; 1995 Aug; 46(4):349-57. PubMed ID: 7595412
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.
Misko IS; Schmidt C; Moss DJ; Burrows SR; Sculley TB
J Gen Virol; 1991 Feb; 72 ( Pt 2)():405-9. PubMed ID: 1704413
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I.
Sabbatini A; Bombardieri S; Migliorini P
Eur J Immunol; 1993 May; 23(5):1146-52. PubMed ID: 8386666
[TBL] [Abstract][Full Text] [Related]
17. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers.
Yao QY; Rowe M; Martin B; Young LS; Rickinson AB
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1579-90. PubMed ID: 1649896
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
19. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
[TBL] [Abstract][Full Text] [Related]
20. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]